Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Applied Therapeutics (APLT) Asset Utilization Ratio (2023 - 2025)

Historic Asset Utilization Ratio for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to 0.03.

  • Applied Therapeutics' Asset Utilization Ratio rose 172570.49% to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year increase of 172570.49%. This contributed to the annual value of 0.01 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Applied Therapeutics reported Asset Utilization Ratio of 0.03 as of Q3 2025, which was up 172570.49% from 0.0 recorded in Q2 2025.
  • Applied Therapeutics' 5-year Asset Utilization Ratio high stood at 0.2 for Q4 2023, and its period low was 0.0 during Q1 2024.
  • For the 3-year period, Applied Therapeutics' Asset Utilization Ratio averaged around 0.03, with its median value being 0.0 (2025).
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 9758.63% in 2024, then surged by 172570.49% in 2025.
  • Applied Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.2 in 2023, then plummeted by 97.59% to 0.0 in 2024, then surged by 478.27% to 0.03 in 2025.
  • Its Asset Utilization Ratio stands at 0.03 for Q3 2025, versus 0.0 for Q2 2025 and 0.0 for Q1 2025.